These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4408256)

  • 1. Letter: Febrile response to cytarabine.
    Bensinger TA; Fahey JL; Kellon DB; Beutler E
    JAMA; 1974 Sep; 229(12):1578. PubMed ID: 4408256
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytarabine syndrome revisited.
    Chng WJ
    Br J Haematol; 2003 Sep; 122(6):875. PubMed ID: 12956755
    [No Abstract]   [Full Text] [Related]  

  • 3. Respiratory insufficiency in acute leukemia following treatment with cytosine arabinoside and septicemia with streptococcus viridans.
    Dybedal I; Lamvik J
    Eur J Haematol; 1989 Apr; 42(4):405-6. PubMed ID: 2721663
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of refractory acute leukemia with high-dose cytosine arabinoside.
    Liu MC; Chen YC; Tsay W; Shen MC; Wang CH; Liu CH
    Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):628-33. PubMed ID: 3655707
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of C-reaction protein for differential diagnosis of fever after chemotherapy on children with acute lymphoblastic leukemia].
    Fang CQ; Tang YM; Li HF; Song H; Shi SW; Yang SL; Xu WQ
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):536-7. PubMed ID: 15324576
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytarabine.
    Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023
    [No Abstract]   [Full Text] [Related]  

  • 9. Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):119-23. PubMed ID: 386480
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine arabinoside (NSC-63878) in acute leukemia in children.
    Howard JP; Cevik N; Murphy ML
    Cancer Chemother Rep; 1966 Jul; 50(5):287-91. PubMed ID: 5936999
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).
    Armitage JO; Burns CP
    Cancer Treat Rep; 1976 May; 60(5):585-9. PubMed ID: 991147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytarabine (Ara-C): a drug profile.
    Berg S
    J Assoc Pediatr Oncol Nurses; 1984; 1(2):30-2. PubMed ID: 6565043
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of secondary acute nonlymphocytic leukemia with cytarabine.
    Preisler HD; Early AP; Raza A; Vlahides G; Marinello MJ; Stein AM; Browman G
    N Engl J Med; 1983 Jan; 308(1):21-3. PubMed ID: 6847919
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.
    Yates JW; Wallace HJ; Ellison RR; Holland JF
    Cancer Chemother Rep; 1973; 57(4):485-8. PubMed ID: 4586956
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Treatment of acute leukaemia.
    Dubovsky D; Jacobs P
    S Afr Med J; 1975 Nov; 49(46):1904. PubMed ID: 1198209
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics.
    Pommier Y; Pochat L; Marie JP; Zittoun RA
    Cancer Treat Rep; 1983 Apr; 67(4):371-3. PubMed ID: 6850654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance management of acute nonlymphocytic leukemia.
    Lewis JP; Pajak TF; Linman JW; Bateman JR
    Cancer Clin Trials; 1981; 4(2):115-24. PubMed ID: 7249249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.